283 related articles for article (PubMed ID: 17206976)
1. Clinical practice evaluation of atosiban in preterm labour management in six European countries.
Husslein P; Roura LC; Dudenhausen J; Helmer H; Frydman R; Rizzo N; Schneider D;
BJOG; 2006 Dec; 113 Suppl 3():105-10. PubMed ID: 17206976
[TBL] [Abstract][Full Text] [Related]
2. Atosiban versus usual care for the management of preterm labor.
Husslein P; Cabero Roura L; Dudenhausen JW; Helmer H; Frydman R; Rizzo N; Schneider D
J Perinat Med; 2007; 35(4):305-13. PubMed ID: 17614750
[TBL] [Abstract][Full Text] [Related]
3. Multicentre, parallel group, randomised, single-blind study of the safety and efficacy of atosiban versus ritodrine in the treatment of acute preterm labour in Korean women.
Shim JY; Park YW; Yoon BH; Cho YK; Yang JH; Lee Y; Kim A
BJOG; 2006 Nov; 113(11):1228-34. PubMed ID: 16978233
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group.
Worldwide Atosiban versus Beta-agonists Study Group
BJOG; 2001 Feb; 108(2):133-42. PubMed ID: 11236112
[TBL] [Abstract][Full Text] [Related]
5. [Effectiveness and safety of atosiban vs. pulsatile administration of fenoterol in the treatment of preterm labour].
Nonnenmacher A; Hopp H; Dudenhausen J
Z Geburtshilfe Neonatol; 2009 Oct; 213(5):201-6. PubMed ID: 19856243
[TBL] [Abstract][Full Text] [Related]
6. Review of clinical experience with atosiban and the Tractocile Efficacy Assessment Survey in Europe (TREASURE) study protocol.
Husslein P; Quartarolo JP
Int J Clin Pract; 2003 Mar; 57(2):121-7. PubMed ID: 12661796
[TBL] [Abstract][Full Text] [Related]
7. Clinical practice evaluation of combination of atosiban, ritodrine and ketoprofen for inhibiting preterm labor.
Grignaffini A; Soncini E; Ronzoni E; Lo Cane F; Anfuso S; Nardelli GB
Minerva Ginecol; 2007 Oct; 59(5):481-9. PubMed ID: 17912174
[TBL] [Abstract][Full Text] [Related]
8. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol.
French/Australian Atosiban Investigators Group
Eur J Obstet Gynecol Reprod Biol; 2001 Oct; 98(2):177-85. PubMed ID: 11574128
[TBL] [Abstract][Full Text] [Related]
9. [Clinical experience of using oxytocin antagonist atosiban in the rescue therapy of preterm labour].
Tan JP; Chen H; Du BJ; Liu YL; Wang YH; Zhang JP
Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):81-4. PubMed ID: 18683742
[TBL] [Abstract][Full Text] [Related]
10. Tocolysis with atosiban: experience in the management of premature labor before 24 weeks of pregnancy.
Richter ON; Dorn C; van de Vondel P; Ulrich U; Schmolling J
Arch Gynecol Obstet; 2005 Jun; 272(1):26-30. PubMed ID: 15909190
[TBL] [Abstract][Full Text] [Related]
11. Atosiban and nifedipine in acute tocolysis: a comparative study.
Al-Omari WR; Al-Shammaa HB; Al-Tikriti EM; Ahmed KW
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):129-34. PubMed ID: 16446025
[TBL] [Abstract][Full Text] [Related]
12. No effect of tocolytic therapy with atosiban on maternal serum interleukin-6 and tumor necrosis factor-alpha in threatened preterm labor.
Vitoratos N; Kountouris A; Makrakis E; Papadias K; Creatsas G
J Matern Fetal Neonatal Med; 2007 Oct; 20(10):725-8. PubMed ID: 17763273
[TBL] [Abstract][Full Text] [Related]
13. [Atosiban treatment for preterm labor--financial considerations and savings by implementing clinical guidelines].
Hadar E; Mansur N; Ambar I; Hod M
Harefuah; 2011 Jun; 150(6):502-6, 553. PubMed ID: 21800486
[TBL] [Abstract][Full Text] [Related]
14. Treatment of preterm labor with the oxytocin antagonist atosiban.
Goodwin TM; Valenzuela G; Silver H; Hayashi R; Creasy GW; Lane R
Am J Perinatol; 1996 Apr; 13(3):143-6. PubMed ID: 8688103
[TBL] [Abstract][Full Text] [Related]
15. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study.
European Atosiban Study Group
Acta Obstet Gynecol Scand; 2001 May; 80(5):413-22. PubMed ID: 11328217
[TBL] [Abstract][Full Text] [Related]
16. The development and introduction of anti-oxytocic tocolytics.
Lamont RF
BJOG; 2003 Apr; 110 Suppl 20():108-12. PubMed ID: 12763125
[TBL] [Abstract][Full Text] [Related]
17. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue.
Romero R; Sibai BM; Sanchez-Ramos L; Valenzuela GJ; Veille JC; Tabor B; Perry KG; Varner M; Goodwin TM; Lane R; Smith J; Shangold G; Creasy GW
Am J Obstet Gynecol; 2000 May; 182(5):1173-83. PubMed ID: 10819855
[TBL] [Abstract][Full Text] [Related]
18. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study.
Moutquin JM; Sherman D; Cohen H; Mohide PT; Hochner-Celnikier D; Fejgin M; Liston RM; Dansereau J; Mazor M; Shalev E; Boucher M; Glezerman M; Zimmer EZ; Rabinovici J
Am J Obstet Gynecol; 2000 May; 182(5):1191-9. PubMed ID: 10819857
[TBL] [Abstract][Full Text] [Related]
19. Clinical practice evaluation of atosiban in preterm labour management in six European countries.
Fallon A; Fallon UB
BJOG; 2007 Aug; 114(8):1043; author reply 1043-4. PubMed ID: 17635490
[No Abstract] [Full Text] [Related]
20. Atosiban and nifedipine in the suppression of pre-term labour: a comparative study.
Saleh SS; Al-Ramahi MQ; Al Kazaleh FA
J Obstet Gynaecol; 2013 Jan; 33(1):43-5. PubMed ID: 23259877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
